| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 0.974 | 39 | 0 | 2001 | 2019 | ||||||||
|
solute carrier family 5 member 2 | 0.499 | 0.769 | 4.9E-14 |
|
group | 0.100 | None | 0.971 | 34 | 0 | 2017 | 2020 | ||||||||
|
cystatin C | 0.436 | 0.808 | 3.9E-03 |
|
group | 0.400 | None | 1.000 | 28 | 0 | 2006 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.300 | None | 0.893 | 28 | 0 | 1994 | 2019 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
group | 0.100 | None | 0.958 | 24 | 0 | 1998 | 2019 | ||||||||
|
IgA nephropathy | 0.524 | 0.808 |
|
group | 0.100 | None | 0.917 | 24 | 0 | 1983 | 2020 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.100 | None | 0.955 | 22 | 0 | 1995 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.864 | 22 | 0 | 2003 | 2019 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
group | 0.400 | None | 1.000 | 21 | 0 | 2006 | 2019 | ||||||||
|
fibroblast growth factor 23 | 0.460 | 0.731 | 3.1E-02 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 2003 | 2019 | ||||||||
|
Rap guanine nucleotide exchange factor 5 | 0.524 | 0.769 | 0.98 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 1983 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 2005 | 2020 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
group | 0.200 | None | 1.000 | 17 | 0 | 2010 | 2020 | ||||||||
|
dipeptidyl peptidase 4 | 0.420 | 0.808 | 7.3E-09 |
|
group | 0.100 | None | 0.941 | 17 | 0 | 2009 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.400 | None | 1.000 | 17 | 0 | 2010 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
group | 0.100 | None | 1.000 | 16 | 0 | 2013 | 2019 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 16 | 0 | 2004 | 2018 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
group | 0.300 | None | 1.000 | 16 | 0 | 2007 | 2019 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1996 | 2019 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2013 | 2020 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2002 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2004 | 2019 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1998 | 2019 | ||||||||
|
polycystin 2, transient receptor potential cation channel | 0.552 | 0.731 | 1.7E-04 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1995 | 2020 | ||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2000 | 2019 |